Can simple checkups predict which kids will get severe pneumonia?
NCT ID NCT07279675
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 67 children hospitalized with pneumonia to find out which early signs—like breathing rate, oxygen levels, or blood tests—best predict a severe case. The goal is to help doctors spot high-risk children sooner and tailor their care. No new treatments are being tested; this is purely about improving how we assess severity.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify which children with pneumonia need more intensive care sooner, potentially reducing complications.
- What could go wrong
- This is an observational study with only 67 children at one hospital, so results may not apply to all kids or settings. It won't test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 67 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children aged 1 month to 5 years of both sexes diagnosed with community-acquired pneumonia (CAP) presenting to the pediatric emergency department or admitted to pediatric wards at Assiut University Children's Hospital during the study period (October 2025 - October 2026). Children with hospital-acquired pneumonia, known immunodeficiency, chronic respiratory diseases, or congenital lung malformations are excluded.
- Ages
-
1 month to 5 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 1 month to 5 years. * Children of both sexes * Onset of illness in the community, not more than 48 hours after hospital admission. Exclusion Criteria: * Children below 1 month, as neonatal pneumonia differs in pathology and management from CAP. * Children with hospital-acquired pneumonia * Known primary or secondary immunodeficiency * Children with chronic respiratory diseases (as cystic fibrosis, bronchiectasis) or congenital lung malformations.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Community-acquired pneumonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test vs. clinical check: which safely cuts antibiotic use in pneumonia?
- Flu vaccine showdown: which shot protects seniors best?
- Can inhaled nitric oxide speed pneumonia recovery?
- Could a lower oxygen threshold get kids home sooner?
- Pneumonia culprit may be rarer than doctors think
- Shorter antibiotic course may be just as effective for kids with pneumonia